European Journal of Neuroscience,
Год журнала:
2020,
Номер
52(8), С. 3944 - 3950
Опубликована: Апрель 23, 2020
Abstract
Obesity
is
a
complex,
chronic,
and
multifactorial
condition
characterized
by
abnormal
fat
accumulation
in
tissues
organs
inducing
negative
effects
on
human
health.
Alzheimer's
disease
progressive
irreversible
neurodegenerative
disease,
associated
with
amyloid
plaques
neurofibrillary
tangles
the
brain.
The
correlation
between
obesity
has
been
discovered,
but
molecules
molecular
mechanisms
linking
these
conditions
are
not
yet
fully
elucidated.
In
this
review,
we
focused
most
important
processes
alterations
of
brain
structure
functions.
Redox Biology,
Год журнала:
2021,
Номер
41, С. 101947 - 101947
Опубликована: Март 20, 2021
Oxidative
stress
has
been
implicated
in
the
pathogenesis
of
Alzheimer's
disease
(AD).
Mitochondrial
dysfunction
is
linked
to
oxidative
and
reactive
oxygen
species
(ROS)
neurotoxicity
during
AD.
Impaired
mitochondrial
metabolism
associated
with
brain
damage
While
role
NADPH
oxidase
4
(NOX4),
a
major
source
ROS,
identified
damage,
mechanism
by
which
NOX4
regulates
ferroptosis
astrocytes
AD
remains
unclear.
Here,
we
show
that
protein
levels
were
significantly
elevated
impaired
cerebral
cortex
from
patients
APP/PS1
double-transgenic
mouse
model
The
4-hydroxynonenal
(4-HNE)
malondialdehyde
(MDA),
marker
stress-induced
lipid
peroxidation,
also
We
demonstrate
over-expression
increases
impairment
inhibition
respiration
ATP
production
via
reduction
five
complexes
ETC
human
astrocytes.
Moreover,
elevation
induces
ROS
(mtROS)
production,
fragmentation,
cellular
antioxidant
process
Furthermore,
increased
ferroptosis-dependent
cytotoxicity
activation
peroxidation
These
results
suggest
promotes
Free Radical Research,
Год журнала:
2019,
Номер
54(1), С. 1 - 26
Опубликована: Дек. 22, 2019
In
aerobes,
oxygen
is
essential
for
maintenance
of
life.
However,
incomplete
reduction
leads
to
generation
reactive
species.
These
oxidants
oxidise
biological
macromolecules
present
in
their
vicinity
and
thereby
impair
cellular
functions
causing
oxidative
stress
(OS).
Aerobes
have
evolved
both
enzymatic
nonenzymatic
antioxidant
defences
protect
themselves
from
OS.
Although
hormones
as
means
coordination
involve
regulation
physiological
activities
tissues
by
regulating
metabolism,
any
change
normal
titre
pathophysiological
states.
While,
such
melatonin,
insulin,
oestrogen,
progesterone
display
features,
thyroid
hormone,
corticosteroids
catecholamines
elicit
free
radical
OS,
the
role
testosterone
inducing
OS
debateable.
This
review
an
attempt
understand
impact
cross
talk
between
modulating
defence
system
under
various
conditions.
Nutrients,
Год журнала:
2020,
Номер
12(11), С. 3367 - 3367
Опубликована: Ноя. 1, 2020
The
increasing
prevalence
of
older
adults
with
diabetes
has
become
a
major
social
burden.
Diabetes,
frailty,
and
cognitive
dysfunction
are
closely
related
to
the
mechanisms
aging.
Insulin
resistance,
arteriosclerosis,
chronic
inflammation,
oxidative
stress,
mitochondrial
may
be
common
shared
by
frailty
impairment.
Hyperglycemia,
hypoglycemia,
obesity,
vascular
factors,
physical
inactivity,
malnutrition
important
risk
factors
for
impairment
in
diabetes.
impact
nutrients
on
health
outcomes
varies
age;
thus,
shifting
diet
therapy
strategies
from
treatment
obesity/metabolic
syndrome
prevention
necessary
patients
who
over
75
years
age,
have
or
sarcopenia,
experience
malnutrition.
For
optimal
energy
intake,
sufficient
protein
vitamin
healthy
dietary
patterns
should
recommended.
after
middle
age
include
awareness
proper
glycemic
control
aimed
at
extending
life
expectancy
nutrition,
exercise,
connectivity.
Nutritional
combination
metabolic
control,
participation/support
can
extend
maintain
quality
mellitus.
Molecular Metabolism,
Год журнала:
2021,
Номер
52, С. 101234 - 101234
Опубликована: Апрель 16, 2021
The
brain
was
once
thought
of
as
an
insulin-insensitive
organ.
We
now
know
that
the
insulin
receptor
is
present
throughout
and
serves
important
functions
in
whole-body
metabolism
function.
Brain
signaling
involved
not
only
homeostatic
processes
but
also
neuropathological
such
cognitive
decline
Alzheimer's
disease.
Pharmacological Research,
Год журнала:
2022,
Номер
176, С. 106062 - 106062
Опубликована: Янв. 10, 2022
Gliflozins
are
a
novel
class
of
oral
anti-diabetic
drugs,
acting
as
inhibitors
sodium-glucose
co-transporters
(SGLTs)
through
the
proximal
convoluted
tubules
(PCT)
and
intestinal
epithelium.
The
2
(SGLT2)
mainly
expressed
in
S1
S2
segments
tubule
kidneys.
Clinical
guidelines
recommend
their
use
especially
Type
Diabetes
mellitus
(T2DM)
patients
with
vascular
complications
and/or
heart
failure
highlighting
importance
co-transporter
(SGLT2i)
pleiotropic
effects.
Interestingly,
cognitive
decline
is
widely
recognized
complication
T2DM
and,
addition,
to
clarify
its
pathophysiology,
there
an
urgent
need
understand
how
if
diabetes
therapies
can
control
diabetes-related
dysfunction.
At
time,
although
SGLT2
proteins
present
Central
Nervous
System
(CNS),
SGLT2i
effects
on
impairments
remain
partly
unknown.
In
pre-clinical
studies,
ameliorates
dysfunction
obese
mice,
reducing
oxidative
stress,
neuroinflammation
improving
neuronal
plasticity
mitochondrial
brain
pathway.
could
bring
back
mTOR
physiological
state
activation,
stopping
neurodegenerative
diseases'
onset
or
progression.
Instead,
clinical
studies
T2DM-related
treated
by
much
more
limited.
For
these
reasons,
further
needed
better
elucidate
therapy
affect
decline.
this
scenario,
review
aims
summarize
knowledge
role
stimulate
new
trials.
Nutrients,
Год журнала:
2024,
Номер
16(4), С. 507 - 507
Опубликована: Фев. 10, 2024
The
escalating
prevalence
of
metabolic
and
cardiometabolic
disorders,
often
characterized
by
oxidative
stress
chronic
inflammation,
poses
significant
health
challenges
globally.
As
the
traditional
therapeutic
approaches
may
sometimes
fall
short
in
managing
these
conditions,
attention
is
growing
toward
nutraceuticals
worldwide;
with
compounds
being
obtained
from
natural
sources
potential
beneficial
effects
shown
to
potentially
support
and,
some
cases,
replace
pharmacological
treatments,
especially
for
individuals
who
do
not
qualify
conventional
treatments.
This
review
delves
into
burgeoning
field
nutraceutical-based
modulation
as
a
promising
strategy
attenuating
inflammation
disorders.
Drawing
an
extensive
body
research,
showcases
various
nutraceutical
agents,
such
polyphenols,
omega-3
fatty
acids,
antioxidants,
which
exhibit
antioxidative
anti-inflammatory
properties.
All
can
be
classified
novel
drugs
that
are
capable
regulating
pathways
mitigate
oxidative-stress-
inflammation-associated
diseases.
By
exploring
mechanisms
through
interact
immune
responses,
this
highlights
their
restore
redox
balance
temper
inflammation.
Additionally,
prospects
interventions
discussed,
encompassing
bioavailability
enhancement,
personalized
treatment
approaches,
clinical
translation.
Through
comprehensive
analysis
latest
scientific
reports,
article
underscores
avenue
fight
complex
landscape
particularly
accentuating
impact
on
cardiovascular
health.
Biomolecules,
Год журнала:
2019,
Номер
9(10), С. 637 - 637
Опубликована: Окт. 22, 2019
This
study
is
the
first
to
assess
diagnostic
utility
of
redox
biomarkers
in
patients
with
colorectal
cancer
(CRC).
Antioxidant
barrier
(Cu,Zn-superoxide
dismutase
(SOD),
catalase
(CAT),
glutathione
peroxidase
(GPx),
reductase
(GR),
uric
acid
(UA),
reduced
(GSH)),
status
(total
antioxidant
(TAC)/oxidant
(TOS),
ferric
reducing
ability
(FRAP)),
and
oxidative
damage
products
(advanced
glycation
end
(AGE),
advanced
oxidation
protein
(AOPP),
malondialdehyde
(MDA))
were
measured
serum/plasma
samples
50
CRC
patients.
The
activity
SOD
was
significantly
higher
whereas
CAT,
GPx
GR
considerably
lower
compared
control
group
(p
<
0.0001).
Levels
UA,
TOS,
OSI
concentrations
AGE,
AOPP,
MDA
higher,
levels
GSH,
TAC,
FRAP
healthy
controls
AUC
for
CAT
respect
presence
lymph
node
metastasis
0.7450
=
0.0036),
according
depth
tumour
invasion
0.7457
0.0118).
associated
enzymatic/non-enzymatic
imbalance
as
well
increased
proteins
lipids.
Redox
can
be
potential
indicators
advancement.
Oxidative Medicine and Cellular Longevity,
Год журнала:
2019,
Номер
2019, С. 1 - 12
Опубликована: Дек. 5, 2019
Despite
the
proven
role
of
oxidative
stress
in
numerous
systemic
diseases
and
process
aging,
little
is
still
known
about
salivary
redox
balance
healthy
children,
adults,
elderly.
Our
study
was
first
to
assess
antioxidant
barrier,
status,
damage
nonstimulated
(NWS)
stimulated
(SWS)
saliva
as
well
blood
samples
individuals
at
different
ages.
We
divided
90
generally
people
into
three
equally
numbered
groups
based
on
age:
2–14
(children
adolescents),
25–45
(adults),
65–85
(elderly
people).
Antioxidant
enzymes
(salivary
peroxidase
(Px),
glutathione
(GPx),
catalase
(CAT),
superoxide
dismutase-1
(SOD)),
nonenzymatic
antioxidants
(reduced
(GSH)
uric
acid
(UA)),
status
(total
capacity
(TAC),
total
oxidant
(TOS),
index
(OSI)),
products
(advanced
glycation
end
(AGE),
advanced
oxidation
protein
(AOPP),
malondialdehyde
(MDA))
were
evaluated
NWS
SWS
erythrocyte/plasma
samples.
demonstrated
that
defense
most
effective
aged
25–45.
In
elderly,
we
observed
a
progressive
decrease
efficiency
central
systems
(↓GPx,
↓SOD,
↓GSH,
↓TAC
erythrocytes
plasma
vs.
adults)
(↓Px,
↓UA,
(↓TAC
adults).
Both
local
less
efficient
children
adolescents
than
group
middle-aged
people,
which
indicates
age-related
immaturity
mechanisms.
Oxidative
proteins
(↑AGE,
↑AOPP)
lipids
(↑MDA)
significantly
higher
elderly
comparison
with
adults
children/adolescents.
Of
all
biomarkers,
only
reflected
their
content
plasma.
The
level
biomarkers
did
not
vary
gender.
Diabetes Care,
Год журнала:
2021,
Номер
45(2), С. 398 - 406
Опубликована: Окт. 29, 2021
OBJECTIVE
Insulin
action
in
the
human
brain
reduces
food
intake,
improves
whole-body
insulin
sensitivity,
and
modulates
body
fat
mass
its
distribution.
Obesity
type
2
diabetes
are
often
associated
with
resistance,
resulting
impaired
brain-derived
modulation
of
peripheral
metabolism.
So
far,
no
pharmacological
treatment
for
resistance
has
been
established.
Since
sodium–glucose
cotransporter
(SGLT2)
inhibitors
lower
glucose
levels
modulate
energy
metabolism,
we
hypothesized
that
SGLT2
inhibition
may
be
a
approach
to
reverse
resistance.
RESEARCH
DESIGN
AND
METHODS
In
this
randomized,
double-blind,
placebo-controlled
clinical
trial,
40
patients
(mean
±
SD;
age
60
9
years;
BMI
31.5
3.8
kg/m2)
prediabetes
were
randomized
receive
25
mg
empagliflozin
every
day
or
placebo.
Before
after
8
weeks
treatment,
sensitivity
was
assessed
by
functional
MRI
combined
intranasal
administration
brain.
RESULTS
We
identified
significant
interaction
between
time
hypothalamic
response
insulin.
Post
hoc
analyses
revealed
only
empagliflozin-treated
experienced
increased
responsiveness.
Hypothalamic
significantly
mediated
empagliflozin-induced
decrease
fasting
liver
fat.
CONCLUSIONS
Our
results
corroborate
hypothalamus
humans
prediabetes.
Treatment
able
restore
favorable
could
contribute
beneficial
effects
inhibitors.
findings
position
as
first
potential
benefits
adiposity
Molecular Psychiatry,
Год журнала:
2022,
Номер
28(1), С. 217 - 229
Опубликована: Окт. 18, 2022
Abstract
Despite
an
ever-growing
prevalence
and
increasing
economic
burden
of
Alzheimer’s
disease
(AD)
Parkinson’s
(PD),
recent
advances
in
drug
development
have
only
resulted
minimally
effective
treatment.
In
AD,
along
with
amyloid
tau
phosphorylation,
there
is
associated
increase
inflammation/glial
activation,
a
decrease
synaptic
function,
astrocyte
state
insulin
resistance.
PD,
α-synuclein
accumulation,
inflammation,
dysfunction,
dopaminergic
neuronal
loss,
some
data
to
suggest
Therapeutic
strategies
for
neurodegenerative
disorders
commonly
targeted
individual
pathological
processes.
An
treatment
might
require
either
utilization
multiple
drugs
which
target
the
processes
underlie
or
use
single
agent
could
influence
Insulin
incretins
are
compounds
effects
on
Preclinical
studies
demonstrated
that
GLP-1
receptor
agonists
reduce
neuroinflammation,
deposition,
improve
memory
formation.
Incretin
mimetics
may
act
through
restoration
signaling
pathways,
inducing
further
neuroprotective
effects.
Currently,
phase
2
3
trials
underway
AD
PD
populations.
Here,
we
provide
comprehensive
review
therapeutic
potential
incretin
PD.